Search

Author/Creator Korse, Catharina M.

1. A Randomized Phase II Study Adding Axitinib to Pemetrexed‐Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single‐Center Trial Combining Clinical and Translational Outcomes. Issue 5 (May 2016)

Authors:
Buikhuisen, Wieneke A.; Scharpfenecker, Marion; Griffioen, Arjan W.; Korse, Catharina M.; van Tinteren, Harm; Baas, Paul
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 5(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal Adenocarcinoma. (April 2019)

Authors:
van der Kaaij, Rosa T.; Voncken, Francine E.M.; van Dieren, Jolanda M.; Snaebjornsson, Petur; Korse, Catharina M.; Grootscholten, Cecile; Aleman, Berthe M.P.; van Sandick, Johanna W.
Journal:
American journal of clinical oncology
Issue:
Volume 42:Number 4(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer. Issue 3 (15th February 2017)

Authors:
Stiekema, Anna; Van de Vijver, Koen K.; Boot, Henk; Broeks, Annegien; Korse, Catharina M.; van Driel, Willemien J.; Kenter, Gemma G.; Lok, Christianne A.R.
Journal:
Cancer cytopathology
Issue:
Volume 125:Issue 3(2017)
Page Start:
197
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗